Literature DB >> 6698980

Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.

G B Villanueva.   

Abstract

The secondary structure of antithrombin III was investigated using the predictive scheme based on the amino acid sequence (Fasman, G. D., Chou, P. Y., and Adler, A. J. (1976) Biophys. J. 16, 1201-1238. The relative composition of the conformational regions is: 31% alpha-helix, 16% beta-sheet, 9% beta-turns, and the rest of the molecule in unordered conformation. When the alpha-helical regions are carefully delineated, 44% are predicted to be unstable helices because of unfavorable electrostatic interactions. Circular dichroism studies showed that the disruption of the first unfolding domain in antithrombin III by low concentration of guanidinium chloride (Villanueva, G. B., and Allen, N. (1983) J. Biol. Chem. 258, 14048-14053) was accompanied by a 42% decrease in the alpha-helical content. This suggested that the first unfolding domain demonstrated to be essential for heparin binding (Villanueva, G. B., and Allen, N. (1983) J. Biol. Chem. 258, 11010-11013) corresponds to the predicted unstable helical region. Model-binding studies of the unstable helical segment which contain tryptophan and lysine residues reveal that Lys-282, Lys-286, and Lys-289 are aligned on the same side of the alpha-helix. A model of the antithrombin III-binding octasaccharide (Lindahl, U., Backstrom, G., Thunberg, L., and Leder, I. G. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 6551-6555) was also constructed based on available NMR and x-ray data of the repeating units in heparin. These two models can be positioned such that the three lysine residues in the alpha-helix can be matched for maximal interaction with the three sulfate groups in the octasaccharide demonstrated as essential for binding antithrombin III. Based on these models, it is proposed that the unstable helical segment composed of residues 281-292 is the heparin-binding site in antithrombin III.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Authors:  Paul C Billings; Maurizio Pacifici
Journal:  Connect Tissue Res       Date:  2015       Impact factor: 3.417

2.  A fragment of antithrombin that binds both heparin and thrombin.

Authors:  L Rosenfeld; I Danishefsky
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  Binding of heparin to human platelet factor 4.

Authors:  S W Cowan; E N Bakshi; K J Machin; N W Isaacs
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

4.  Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.

Authors:  Pierre F Neuenschwander; Stephen R Williamson; Armen Nalian; Kimberly J Baker-Deadmond
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

5.  The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.

Authors:  R C Austin; W P Sheffield; R A Rachubinski; M A Blajchman
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

6.  Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.

Authors:  Younan Chen; Weidong Tan; Shengfang Qin; Jie Zhang; Hong Bu; Youping Li; Yanrong Lu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

7.  Effect of heparin on the glia-derived-nexin-thrombin interaction.

Authors:  A Wallace; G Rovelli; J Hofsteenge; S R Stone
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.